Furthermore, the combination of PD-L1-CAR T cell injection with local radiotherapy enhanced the efficacy of PD-L1-CAR T cells against PD-L1 NSCLC cells and tumors (147). This evidence concerns the gene CD274 and non-small cell lung carcinoma.